Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

82.35
+1.251.54%
Post-market: 82.350.00000.00%17:38 EST
Volume:463.17K
Turnover:38.32M
Market Cap:1.85B
PE:-126.86
High:83.58
Open:81.37
Low:81.19
Close:81.10
52wk High:99.50
52wk Low:52.50
Shares:22.47M
Float Shares:20.38M
Volume Ratio:1.22
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6491
EPS(LYR):-1.0429
ROE:8.66%
ROA:2.49%
PB:3.66
PE(LYR):-78.96

Loading ...

Does a common heart attack pill help everyone? Studies disagree

Reuters
·
Aug 30

Director Matthew J. Leonard Reports Disposal of Common Shares in ANI Pharmaceuticals Inc

Reuters
·
Aug 27

ANI Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire
·
Aug 26

Krista Davis, SVP and Chief HR Officer, Reports Disposal of Common Shares of ANI Pharmaceuticals Inc

Reuters
·
Aug 26

Muthusamy Shanmugam, Head of R&D and COO-Novitium Ops, Reports Disposal of ANI Pharmaceuticals Inc. Common Shares

Reuters
·
Aug 23

Director Antonio R. Pera Reports Disposal of Common Shares of ANI Pharmaceuticals Inc

Reuters
·
Aug 21

Director Patrick D. Walsh Reports Disposal of Common Shares in ANI Pharmaceuticals Inc

Reuters
·
Aug 19

Shanmugam Muthusamy, Head of R&D, Reports Disposal of Common Shares in ANI Pharmaceuticals Inc

Reuters
·
Aug 19

SVP Chad Gassert Reports Disposal of Common Shares in ANI Pharmaceuticals Inc

Reuters
·
Aug 19

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Berkshire Hathaway, Chevron

Reuters
·
Aug 18

ANI Pharmaceuticals Inc : Jefferies Raises Target Price to $120 From $80

THOMSON REUTERS
·
Aug 18

Ori Gutwerg, SVP of Generics, Reports Disposal of ANI Pharmaceuticals Inc. Common Shares

Reuters
·
Aug 15

ANI Pharmaceuticals Inc. CFO Stephen P. Carey Reports Disposal of Common Shares

Reuters
·
Aug 15

Stock Track | ANI Pharmaceuticals Soars 5.09% as Analysts Boost Price Targets

Stock Track
·
Aug 11

Stock Track | ANI Pharmaceuticals Soars 5% as Analysts Boost Price Targets Post Strong Q2 Earnings

Stock Track
·
Aug 11

ANI Pharmaceuticals Inc : Raymond James Raises Target Price to $99 From $86

THOMSON REUTERS
·
Aug 11

Truist Securities Adjusts ANI Pharmaceuticals Price Target to $77 From $65, Maintains Hold Rating

MT Newswires Live
·
Aug 11

ANI Pharmaceuticals Up Nearly 18%, on Track for Highest Close Since August 2019 -- Data Talk

Dow Jones
·
Aug 09

ANI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 09

Stock Track | ANI Pharmaceuticals Soars 17% on Record Q2 Results and Raised 2025 Guidance

Stock Track
·
Aug 08